Shares of Charles River Laboratories International Inc. rose 4.30% to $233.60 Thursday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index rising ...

Charles River management believes that supplementary non-GAAP financial measures provide useful information to allow investors to gain a meaningful understanding of our core operating results and ...

Shares of Charles River Laboratories International Inc. CRL slid 1.19% to $228.68 Tuesday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index SPX ...

Ladies and gentlemen, thank you for standing by, and welcome to the Charles River Laboratories Fourth Quarter and Full Year 2025 Earnings Conference Call. This call is being recorded. [Operator ...

Bio-Rad provides essential instruments and reagents used in labs worldwide, while Charles River offers critical research models and services for drug discovery. Investors often compare these two ...